Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NUFARM LIMITED Director's Dealing 2015

Nov 15, 2015

65453_rns_2015-11-15_79caa8ed-e37a-4024-ba05-b983a0bacd9f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity NUFARM LIMITED ABN 37 091 323 312

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director WILLIAM BRUCE GOODFELLOW
Date of last notice 5/6/2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Sulkem Company Ltd
Date of change 13/ 11/2015
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change Direct:112,488 Fully Paid Ordinary SharesIndirect:Pacific Custodians Pty Ltd – 31,585 FullyPaid Ordinary SharesMA Goodfellow – 13,000 Fully PaidOrdinary Shares and 100 NSSSt Kentigern Trust – 430,434 Fully PaidOrdinary Shares and 19,727 NSSSulkem Company Ltd – 126,493 Fully PaidOrdinary SharesAuckland Medical Research Foundation –26,558 NSSTrustees of The Goodfellow Foundation –33,854 Fully Paid OrdinaryShares and 1,338 NSSWB Goodfellow and Edgar WilliamPreston as Trustees of the 531Trust – 400,861 Fully PaidOrdinary SharesArchem Trading (NZ) Ltd - 700 NSS
Class Ordinary
Number acquired Direct: 226 Fully Paid Ordinary SharesIndirect: (Sulkem Company Ltd) 907 FullyPaid Ordinary Shares
Number disposed Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation $8.3691
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Direct:
112,714 Fully Paid Ordinary Shares
Indirect:
Pacific Custodians Pty Ltd – 31,585 Fully
Paid Ordinary Shares
MA Goodfellow – 13,000 Fully Paid
Ordinary Shares and 100 NSS
St Kentigern Trust – 430,434 Fully Paid
Ordinary Shares and 19,727 NSS
Sulkem Company Ltd – 127,400 Fully Paid
Ordinary Shares
Auckland Medical Research Foundation –
26,558 NSS
Trustees of The Goodfellow Foundation –
33,854 Fully Paid Ordinary
Shares and 1,338 NSS
WB Goodfellow and Edgar William
Preston as Trustees of the 531
Trust – 400,861 Fully Paid
Ordinary Shares
Archem Trading (NZ) Ltd - 700 NSS
Nature of change Shares Issued under the Company’s
Example: on-market trade, off-market trade, exercise of options, issue of Dividend Reinvestment Plan
securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011